Literature DB >> 5428626

Continuous intravenous infusion of factor VIII in classic haemophilia.

C W McMillan, W P Webster, H R Roberts, W B Blythe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5428626     DOI： 10.1111/j.1365-2141.1970.tb01591.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  7 in total

1.  Effective management of intracranial haemorrhage with continuous infusion of highly purified von Willebrand factor/factor VIII complex concentrate in an adult with severe haemophilia A.

Authors:  Filomena Daniele; Vincenza Rossi; Caterina Santoro
Journal:  Blood Transfus       Date:  2011-06-15       Impact factor: 3.443

Review 2.  Total knee arthroplasty in severe haemophilic patients under continuous infusion of clotting factors.

Authors:  M Rahmé; M Ehlinger; A Faradji; N Gengenwin; J Lecocq; J Sibilia; F Bonnomet
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-11-24       Impact factor: 4.342

Review 3.  Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia.

Authors:  S Björkman; E Berntorp
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

4.  Cost-utility analysis of primary prophylaxis versus treatment on-demand for individuals with severe haemophilia.

Authors:  Alexander H Miners; Caroline A Sabin; Keith H Tolley; Christine A Lee
Journal:  Pharmacoeconomics       Date:  2002       Impact factor: 4.981

5.  Survival of 125iodine-labeled Factor VIII in normals and patients with classic hemophilia. Observations on the heterogeneity of human Factor VIII.

Authors:  J Over; J J Sixma; M H Bruïne; M C Trieschnigg; R A Vlooswijk; N H Beeser-Visser; B N Bouma
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

6.  Comparison of continuous infusion versus bolus injection of factor concentrates for blood management after total knee arthroplasty in patients with hemophilia.

Authors:  Young Shil Park; Won-Ju Shin; Kang-Il Kim
Journal:  BMC Musculoskelet Disord       Date:  2017-08-22       Impact factor: 2.362

Review 7.  Continuous infusion of recombinant activated factor VII: a review of data in congenital hemophilia with inhibitors and congenital factor VII deficiency.

Authors:  Madhvi Rajpurkar; David L Cooper
Journal:  J Blood Med       Date:  2018-11-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.